Article
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
16 Jan 2019
Abstract excerpt
BACKGROUND: In osteosarcoma (OS), chemotherapy resistance has become one of the greatest issues leading to high mortality among patients. However, the mechanisms of drug resistance remain elusive, limiting therapeutic efficacy. Here, we set out to explore the relationship between dynamic histone changes and the efficacy of cisplatin against OS. RESULTS: First, we found two histone demethylases associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
